Creston plc Now Covered by Sanlam Securities (CRE)
Research analysts at Sanlam Securities assumed coverage on shares of Creston plc (LON:CRE) in a report released on Friday. The firm set a “buy” rating and a GBX 150 ($2.48) price target on the stock. Sanlam Securities’ price objective indicates a potential upside of 36.05% from the stock’s previous close.
Creston plc (LON:CRE) opened at 111.50 on Friday. Creston plc has a 52-week low of GBX 81.00 and a 52-week high of GBX 116.00. The stock’s 50-day moving average is GBX 105.4 and its 200-day moving average is GBX 106.5. The company’s market cap is £66.3 million.
Separately, analysts at Liberum Capital reiterated a “buy” rating on shares of Creston plc in a research note on Thursday, June 19th. They now have a GBX 125 ($2.07) price target on the stock. Five analysts have rated the stock with a buy rating, The company presently has a consensus rating of “Buy” and an average price target of GBX 128.25 ($2.12).
Creston Plc is a United Kingdom-based company engaged in insight and communications services. The Company operates in three divisions: Communications division, which offers clients an integrated approach to their marketing and communication strategy, offering a range of services, which include advertising, brand strategy, channel marketing, customer relationship marketing, digital marketing, direct marketing, local marketing, social media marketing and public relations; Health division, which provides an integrated communications solution to the healthcare and pharmaceutical sector and offers services, which include advertising, advocacy, digital and direct marketing, public relations, issues and reputation management and medical education; Insight division, which performs a range of market research services on behalf of its clients, through both qualitative and quantitative means, using face-to-face, telephone and online data collection techniques.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.